Harper Sean E
EVP, Research & Development at AMGN
- Sold, on record
- $16.9M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Jul 16, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AMGNAMGEN INCEVP, Research & Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AMGNPlan not statedDec 12, 2017 2017
Sold 1,525 shares at $176.83 ($270k)
Harper Sean E, EVP, Research & Development
Sold 2.6% of holdings ($10.2M position)56,106 shares left1x usual sizeFiling
- 2 Form 4 sale AMGNPlan not statedJan 16, 2018 +35 days
Sold 1,525 shares at $185.62 ($283k)
Harper Sean E, EVP, Research & Development
Sold 2.7% of holdings ($10.4M position)54,673 shares left1x usual sizeFiling
- 3 Form 4 sale AMGNPlan not statedFeb 14, 2018 +29 days
Sold 1,525 shares at $174.18 ($266k)
Harper Sean E, EVP, Research & Development
Sold 2.8% of holdings ($9.3M position)52,089 shares left1x usual sizeFiling
- 4 Form 4 sale AMGNPlan not statedMar 16, 2018 +30 days
Sold 1,525 shares at $189.75 ($289k)
Harper Sean E, EVP, Research & Development
Sold 2.3% of holdings ($12.8M position)65,682 shares left1x usual sizeFiling
- 5 Form 4 sale AMGNPlan not statedApr 12, 2018 +27 days
Sold 1,525 shares at $172.68 ($263k)
Harper Sean E, EVP, Research & Development
Sold 2.6% of holdings ($10.1M position)56,788 shares left1x usual sizeFiling
- 6 Form 4 sale AMGNPlan not statedMay 14, 2018 +32 days
Sold 1,525 shares at $174.10 ($266k)
Harper Sean E, EVP, Research & Development
Sold 2.5% of holdings ($10.5M position)59,035 shares left1x usual sizeFiling
- 7 Form 4 sale AMGNPlan not statedJun 12, 2018 +29 days
Sold 1,525 shares at $184.27 ($281k)
Harper Sean E, EVP, Research & Development
Sold 2.6% of holdings ($10.9M position)57,510 shares left1x usual sizeFiling
- 8 Form 4 sale AMGNPlan not statedJul 16, 2018 +34 days
Sold 1,525 shares at $195.71 ($298k)
Harper Sean E, EVP, Research & Development
Sold 2.6% of holdings ($11.3M position)56,082 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2018 | Jul 16, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $298k | 2.6% | Plan not stated | SEC |
| Jun 12, 2018 | Jun 12, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $281k | 2.6% | Plan not stated | SEC |
| May 14, 2018 | May 15, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $266k | 2.5% | Plan not stated | SEC |
| Apr 12, 2018 | Apr 16, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $263k | 2.6% | Plan not stated | SEC |
| Mar 16, 2018 | Mar 19, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $289k | 2.3% | Plan not stated | SEC |
| Feb 14, 2018 | Feb 15, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $266k | 2.8% | Plan not stated | SEC |
| Jan 16, 2018 | Jan 17, 2018 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $283k | 2.7% | Plan not stated | SEC |
| Dec 12, 2017 | Dec 12, 2017 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $270k | 2.6% | Plan not stated | SEC |
| Nov 13, 2017 | Nov 14, 2017 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $262k | 2.6% | Plan not stated | SEC |
| Oct 9, 2017 | Oct 10, 2017 | AMGN | EVP, Research & Development | Form 4 sale | 1,525 | $284k | 2.5% | Plan not stated | SEC |
| Apr 29, 2016 | May 3, 2016 | AMGN | EVP, Research & Development | Form 4 sale | 21,875 | $3.5M | 34.1% | Unusual | SEC |
| Apr 22, 2015 | Apr 23, 2015 | AMGN | EVP, Research & Development | Form 4 sale | 28,000 | $4.8M | 36.9% | Unusual | SEC |
| Aug 5, 2014 | Aug 7, 2014 | AMGN | EVP, Research & Development | Form 4 sale | 14,000 | $1.8M | 19.0% | Plan not stated | SEC |
| May 2, 2013 | May 6, 2013 | AMGN | EVP, Research & Development | Form 4 sale | 8,000 | $851k | 11.1% | Plan not stated | SEC |
| Jul 27, 2012 | Jul 31, 2012 | AMGN | EVP, Research & Development | Form 4 sale | 39,900 | $3.3M | 43.2% | Unusual | SEC |